What is the treatment for viral conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Viral Conjunctivitis

Viral conjunctivitis is primarily managed with supportive care as it is typically self-limiting, with specific antiviral treatments reserved for certain viral types such as herpes simplex virus (HSV) and varicella zoster virus (VZV). 1

Types of Viral Conjunctivitis and Their Management

Adenoviral Conjunctivitis (Most Common)

  • Treatment approach: Supportive care only
  • Specific measures:
    • Artificial tears for symptomatic relief
    • Cold compresses to reduce inflammation and discomfort
    • Antihistamine eye drops for itching
    • No role for antibiotics unless secondary bacterial infection 2
  • For severe cases with subepithelial infiltrates:
    • If vision is affected, topical corticosteroids at minimum effective dose may be considered 3
    • Corticosteroids with poor ocular penetration (fluorometholone) or site-specific corticosteroids (rimexolone, loteprednol) are preferred to minimize IOP elevation and cataract formation 1
    • Regular monitoring of IOP required if steroids are used

Herpes Simplex Virus Conjunctivitis

  • Treatment required upon high suspicion or corneal involvement 1
  • Topical options:
    • Ganciclovir 0.15% gel three to five times per day (preferred due to lower ocular toxicity)
    • Trifluridine 1% solution five to eight times per day (limit to 2 weeks due to epithelial toxicity)
  • Oral options:
    • Acyclovir 200-400 mg five times daily
    • Valacyclovir 500 mg two or three times daily
    • Famciclovir 250 mg twice daily
  • Important caution: Avoid topical corticosteroids as they potentiate HSV infection 1
  • Follow-up: Within 1 week of treatment with visual acuity measurement and slit-lamp examination

Varicella Zoster Virus Conjunctivitis

  • For persistent/recalcitrant disease:
    • Oral antivirals: Acyclovir 800 mg five times daily for 7 days, valacyclovir 1000 mg every 8 hours for 7 days, or famciclovir 500 mg three times daily for 7 days 1
  • Topical antibiotics may be used to prevent secondary infection of vesicles
  • Note: Topical antivirals alone are not effective but may be used as adjunctive therapy in unresponsive cases

Molluscum Contagiosum-Associated Conjunctivitis

  • Treatment: Remove the eyelid lesions causing viral shedding onto the ocular surface
  • Removal techniques:
    • Incision and curettage (aggressive enough to cause bleeding)
    • Simple excision
    • Excision and cautery
    • Cryotherapy
  • Follow-up: Not usually necessary unless conjunctivitis persists after lesion removal

Prevention of Transmission

  • Strict hygiene measures are essential to prevent spread:
    • Frequent handwashing
    • Avoid sharing towels and pillowcases
    • Change pillowcases frequently during infection
    • Avoid touching or rubbing eyes 3
  • Return to work/school: Patients with viral conjunctivitis should minimize contact with others for 10-14 days from symptom onset 3

When to Refer to an Ophthalmologist

  • Visual loss
  • Moderate to severe pain
  • Corneal involvement
  • Conjunctival scarring
  • Lack of response to therapy after 3-4 days
  • Recurrent episodes
  • History of herpes simplex virus eye disease
  • Immunocompromised status 3, 2
  • Neonates with conjunctivitis (requires immediate consultation) 1

Common Pitfalls to Avoid

  • Inappropriate use of antibiotics for viral conjunctivitis
  • Prolonged use of corticosteroids without ophthalmology supervision
  • Failure to recognize potentially serious causes of conjunctivitis
  • Inadequate hygiene education
  • Delayed referral for severe or non-responsive cases 3

Remember that viral conjunctivitis accounts for approximately 80% of all acute conjunctivitis cases, with adenovirus being the most common causative agent 4. While most cases are self-limiting, early diagnosis and appropriate management can help alleviate symptoms and prevent complications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Conjunctivitis: Diagnosis and Management.

American family physician, 2024

Guideline

Bacterial Conjunctivitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Viral Conjunctivitis.

Viruses, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.